On the other hand, the association between systemic levels of CCL11/eotaxin-1 and the risk of CAD was examined in the PRIME study—study with 10 years of follow-up of 9771 male participants—but it was not an independent predictor of coronary event [42]. The gene discussed is CCL11; the disease is coronary artery disorder.